← FDA Drug Approvals (Drugs@FDA)
TAPENTADOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WEST-WARD PHARMS INT · Approved 2026-02-13
Drug application
- FDA Application #
ANDA206418- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TAPENTADOL
- Generic name
- Tapentadol
- Active ingredients
- TAPENTADOL
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- WEST-WARD PHARMS INT
- First approval
- 2026-02-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown